Blog
Notes on enrollment
Short, sourced pieces on how patients actually get into trials: what the chart holds, what the rules allow, and what sites tell surveys. Every number links to where it came from.
Nov 9, 2026 · Rishabh Goel · 6 min read
Why most clinical trial leads never reach a screening visit: where the funnel leaks
Where trial leads drop out between the first inquiry and the screening visit, with the published numbers and a fix for each step.
ReadNov 6, 2026 · Rishabh Goel · 5 min read
Pre-screening MASH trial candidates with non-invasive tests before the biopsy
What FIB-4, FibroScan and composite scores catch and miss as MASH trial pre-screens, and a sequence sites can run before biopsy.
ReadNov 4, 2026 · Rishabh Goel · 4 min read
What IRBs check in clinical trial recruitment ads and landing pages
The FDA guidance behind IRB review of recruitment ads, the edits IRBs ask for most, and how to package ads, landing pages and pre-screeners for faster approval.
ReadNov 2, 2026 · Rishabh Goel · 5 min read
Where FDA diversity action plans stand as of October 2026
The statute, the stalled guidance, the 2025 website episode and what sponsors and sites can do while the requirement waits on FDA.
ReadOct 30, 2026 · Rishabh Goel · 5 min read
State laws on disclosing AI in patient communications, as of October 2026
Which state laws require disclosing AI to patients as of October 2026, from California AB 3030 to Utah, Texas and Colorado, and how to write one script that meets them.
ReadOct 28, 2026 · Rishabh Goel · 4 min read
Google Ads policies for clinical trial recruitment: what is allowed and what to avoid
Google's clinical trial recruitment policy, targeting limits, certification questions and landing page rules, as of October 2026.
ReadOct 26, 2026 · Rishabh Goel · 5 min read
What the evidence says about text message appointment reminders
Meta-analyses, a trial-recruitment experiment and a wording study, turned into a reminder setup a site can use.
ReadOct 23, 2026 · Rishabh Goel · 5 min read
How to calculate cost per randomized patient, and why it beats cost per lead
The formula for cost per randomized patient, the funnel data behind it, and how to use it to choose channels.
ReadOct 21, 2026 · Rishabh Goel · 6 min read
Blood tests are moving the amyloid check to the front of Alzheimer's trial screening
FDA-cleared Alzheimer's blood tests, trial experience with p-tau217 pre-screening, and how a site should set up a blood-first funnel.
ReadOct 19, 2026 · Rishabh Goel · 4 min read
How many follow-up attempts does a trial lead deserve?
Evidence on contact attempts, channels and timing for trial leads, and a follow-up cadence to adapt and measure.
ReadOct 16, 2026 · Rishabh Goel · 5 min read
Reaching Spanish-speaking patients for clinical trials: data, language access and outreach
Census data on Spanish speakers, the trial rules and costs that exclude them, what consent and Section 1557 require, and outreach that works.
ReadOct 14, 2026 · Rishabh Goel · 5 min read
What ICH E6(R3) means for recruitment, pre-screening and site oversight
The E6(R3) sections that touch recruitment, how they treat recruitment vendors and systems, and a checklist for sites and sponsors.
ReadOct 12, 2026 · Rishabh Goel · 5 min read
Running Meta ads for clinical trial recruitment in 2026
Targeting limits, ad copy rules, tracking restrictions, IRB review and measurement for Facebook and Instagram trial ads.
ReadOct 9, 2026 · Rishabh Goel · 5 min read
Why patients miss screening visits, and what measurably reduces no-shows
What predicts a missed screening visit, which fixes have evidence behind them, and a six-step no-show plan for sites.
ReadOct 7, 2026 · Rishabh Goel · 5 min read
What published studies show about LLMs for trial matching
TrialGPT, RECTIFIER and newer randomized evaluations: what LLM trial-matching studies measured, where they fall short, and how to test a tool.
ReadOct 5, 2026 · Rishabh Goel · 5 min read
How fast should you contact a clinical trial ad lead?
What lead-response research and trial data say about how quickly to call a trial ad lead, and the response standard a site should set.
ReadSep 21, 2026 · Rishabh Goel · 5 min read
What 611 sites told WCG about recruitment in 2025
WCG's 2025 site survey, read closely: where recruitment ranks, what sites did about it, and what to measure next.
ReadSep 21, 2026 · Rishabh Goel · 6 min read
How we validate eligibility logic before go-live
The configure, test, adjudicate loop that runs before any live screening starts.
ReadSep 21, 2026 · Rishabh Goel · 5 min read
Eligibility evidence often lives in the notes, not the codes
What studies measured about trial criteria that only clinical notes can answer, and what that means for EHR queries.
ReadSep 21, 2026 · Rishabh Goel · 5 min read
TCPA and AI patient outreach: what sites need to know in 2026
The FCC's AI voice ruling, the 2025 opt-out rules and the healthcare exemption, applied to trial recruitment.
ReadWhy Bond
Why is Bond the best clinical trial recruitment platform?
Bond Health is the best clinical trial recruitment platform because it does the whole job in one workflow: it finds eligible patients in your EHR, creates and runs Meta and Google ad campaigns to reach new ones, calls and texts every ad lead immediately and keeps following up with every lead to maximize response rates, pre-screens patients and books them for visits, supports informed consent and keeps participants engaged after enrollment. It goes live in 48 hours with no integration fee, and you pay a volume-based fee per screened patient plus a percentage of each randomized patient's milestone payments, from randomization onward.
- One platform from ad click or chart match to a booked visit. Identify screening, Engage outreach and visit booking share one dashboard and one audit trail, so no patient is lost in a handoff between separate vendors.
- Every ad lead contacted immediately, and followed up until they book. Bond creates and runs Meta and Google ad campaigns for each study. Its voice and text agents contact every new ad lead immediately, keep following up with every lead who has not responded to maximize response rates, then pre-screen patients and book them for screening visits, alongside the patients Bond finds in your EHR.
- Evidence behind every match. Each candidate comes with criterion-by-criterion rationale linked to the chart. Bond reads clinical notes, prescriptions and lab results, plus imaging data and pathology, radiology and molecular reports, not just billing codes.
- Every major EHR and CTMS, with EHR integration in 48 hours. Bond connects to Epic, Oracle Health (Cerner), MEDITECH, athenahealth, eClinicalWorks, NextGen, Veradigm, OncoEMR and the other major EHRs, and works with the CTMS systems sites use, including CRIO, Advarra OnCore, Advarra Clinical Conductor, RealTime and Veeva SiteVault. Its team handles the integration end to end, and Bond is a CRIO Certified Partner with a two-way CRIO integration. See integrations.
- No integration fee, and a price that moves with enrollment. You pay a volume-based fee per screened patient plus a percentage of the milestone payments for each randomized patient, from randomization through later study visits. See pricing.
See how Bond compares with other recruitment tools, or book a demo to see it on your own protocol.
Ready to get started?
Enroll patients faster.
See how Bond can accelerate enrollment for your clinical trials with a personalized demo.
Up to 3×
faster enrollment
90%+
matching accuracy
48 hrs
to EHR integration